Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022

被引:0
|
作者
Lambrou, Anastasia S. [1 ,2 ]
Shirk, Philip [1 ]
Steele, Molly K. [1 ]
Paul, Prabasaj [1 ]
Paden, Clinton R. [1 ]
Cadwell, Betsy [1 ]
Reese, Heather E. [1 ]
Aoki, Yutaka [1 ]
Hassell, Norman [1 ]
Zheng, Xiao-Yu [3 ]
Talarico, Sarah [1 ]
Chen, Jessica C. [1 ]
Oberste, M. Steven [1 ]
Batra, Dhwani [1 ]
McMullan, Laura K. [1 ]
Halpin, Alison Laufer [1 ]
Galloway, Summer E. [1 ]
MacCannell, Duncan R. [4 ]
Kondor, Rebecca [1 ]
Barnes, John [1 ]
MacNeil, Adam [1 ]
Silk, Benjamin J. [1 ]
Dugan, Vivien G. [1 ]
Scobie, Heather M. [1 ]
Wentworth, David E. [1 ]
机构
[1] CDC, COVID 19 Emergency Response Team, Atlanta, GA 30333 USA
[2] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA
[3] Gen Dynam Informat Technol, Falls Church, VA USA
[4] CDC, Off Adv Mol Detect, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
What is already known about this topic? CDC conducts genomic surveillance to track SARS-CoV-2 variants in the United States. What is added by this report? CDC's SARS-CoV-2 genomic surveillance has been expanded to incorporate sequence data from public repositories and to produce weighted estimates of variant proportions at the jurisdiction level. The Delta (B.1.617.2 and AY sublineages) variant rose to predominance in late June 2021, followed by the rapid rise of Omicron (B.1.1.529 and BA sublineages) in December 2021. What are the implications for public health practice? The dynamic landscape of SARS-CoV-2 variants in 2021, including Delta- and Omicron-driven resurgences of SARS-CoV-2 transmission across the United States, underscores the importance of robust genomic surveillance efforts to inform public health planning and practice.
引用
收藏
页码:206 / 211
页数:6
相关论文
共 50 条
  • [1] Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022 (vol 71, 2022)
    Lambrou, Anastasia S.
    Shirk, Philip
    Steele, Molly K.
    Paul, Prabasaj
    Paden, Clinton R.
    Cadwell, Betsy
    Reese, Heather E.
    Aoki, Yutaka
    Hassell, Norman
    Caravas, Jason
    Kovacs, Nicholas A.
    Gerhart, Jonathan G.
    Ng, Han Jia
    Zheng, Xiao-yu
    Beck, Andrew
    Chau, Reina
    Cintron, Roxana
    Cook, Peter W.
    Gulvik, Christopher A.
    Howard, Dakota
    Jang, Yunho
    Knipe, Kristen
    Lacek, Kristine A.
    Moser, Kara A.
    Paskey, Adrian C.
    Rambo-Martin, Benjamin L.
    Nagilla, Roopa R.
    Retchless, Adam C.
    Schmerer, Matthew W.
    Seby, Sandra
    Shepard, Samuel S.
    Stanton, Richard A.
    Stark, Thomas J.
    Uehara, Anna
    Unoarumhi, Yvette
    Bentz, Meghan L.
    Burgin, Alex
    Burroughs, Mark
    Davis, Morgan L.
    Keller, Matthew W.
    Keong, Lisa M.
    Le, Shoshona S.
    Lee, Justin S.
    Madden, Joseph C., Jr.
    Nobles, Sarah
    Owuor, D. Collins
    Padilla, Jasmine
    Sheth, Mili
    Wilson, Malania M.
    Talarico, Sarah
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (14): : 528 - 528
  • [2] SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
    Khemiri, Haifa
    Ayouni, Kaouther
    Triki, Henda
    Haddad-Boubaker, Sondes
    [J]. VIROLOGY JOURNAL, 2022, 19 (01)
  • [3] SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
    Haifa Khemiri
    Kaouther Ayouni
    Henda Triki
    Sondes Haddad-Boubaker
    [J]. Virology Journal, 19
  • [4] Is Omicron really mild?-Comparative analysis of comorbidities and disease outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants
    Manchanda, Vikas
    Mitra, Srestha
    Rafique, Iram
    Sharma, Anju
    Dhakad, Megh Singh
    Saxena, Sonal
    Kapoor, Seema
    Kumar, Suresh
    [J]. INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2023, 45
  • [5] Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England
    Allen, Hester
    Tessier, Elise
    Turner, Charlie
    Anderson, Charlotte
    Blomquist, Paula
    Simons, David
    Lochen, Alessandra
    Jarvis, Christopher I.
    Groves, Natalie
    Capelastegui, Fernando
    Flannagan, Joe
    Zaidi, Asad
    Chen, Cong
    Rawlinson, Christopher
    Hughes, Gareth J.
    Chudasama, Dimple
    Nash, Sophie
    Thelwall, Simon
    Lopez-Bernal, Jamie
    Dabrera, Gavin
    Charlett, Andre
    Kall, Meaghan
    Lamagni, Theresa
    [J]. EPIDEMIOLOGY & INFECTION, 2023, 151
  • [6] Differences in Immunological Evasion of the Delta (B.1.617.2) and Omicron (B.1.1.529) SARS-CoV-2 Variants: A Retrospective Study on the Veneto Region's Population
    Cocchio, Silvia
    Zabeo, Federico
    Facchin, Giacomo
    Piva, Nicolo
    Venturato, Giovanni
    Marcon, Thomas
    Saia, Mario
    Tonon, Michele
    Mongillo, Michele
    Da Re, Filippo
    Russo, Francesca
    Baldo, Vincenzo
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (13)
  • [7] Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
    Nyberg, Tommy
    Ferguson, Neil M.
    Nash, Sophie G.
    Webster, Harriet H.
    Flaxman, Seth
    Andrews, Nick
    Hinsley, Wes
    Bernal, Jamie Lopez
    Kall, Meaghan
    Bhatt, Samir
    Blomquist, Paula
    Zaidi, Asad
    Volz, Erik
    Aziz, Nurin Abdul
    Harman, Katie
    Funk, Sebastian
    Abbott, Sam
    Hope, Russell
    Charlett, Andre
    Chand, Meera
    Ghani, Azra C.
    Seaman, Shaun R.
    Dabrera, Gavin
    De Angelis, Daniela
    Presanis, Anne M.
    Thelwall, Simon
    [J]. LANCET, 2022, 399 (10332): : 1303 - 1312
  • [8] Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England
    Ekroth, Alice K. E.
    Patrzylas, Piotr
    Turner, Charlie
    Hughes, Gareth J.
    Anderson, Charlotte
    [J]. EPIDEMIOLOGY AND INFECTION, 2022, 150
  • [9] Performance of 20 rapid antigen detection tests to detect SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variants using a clinical specimen panel from January 2022, Berlin, Germany
    Puyskens, Andreas
    Bayram, Fatimanur
    Sesver, Akin
    Michel, Janine
    Krause, Eva
    Bourquain, Daniel
    Filomena, Angela
    Esser-Nobis, Katharina
    Steffanowski, Carla
    Nuebling, C. Micha
    Scheiblauer, Heinrich
    Schaade, Lars
    Nitsche, Andreas
    [J]. EUROSURVEILLANCE, 2023, 28 (16)
  • [10] Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients
    Benning, Louise
    Morath, Christian
    Bartenschlager, Marie
    Kim, Heeyoung
    Reineke, Marvin
    Beimler, Jorg
    Buylaert, Mirabel
    Nusshag, Christian
    Kaelble, Florian
    Reichel, Paula
    Toellner, Maximilian
    Schaier, Matthias
    Klein, Katrin
    Benes, Vladimir
    Rausch, Tobias
    Rieger, Susanne
    Stich, Maximilian
    Toenshoff, Burkhard
    Weidner, Niklas
    Schnitzler, Paul
    Zeier, Martin
    Susal, Caner
    Tran, Thuong Hien
    Bartenschlager, Ralf
    Speer, Claudius
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (07) : 1873 - 1883